Shiga toxin pathogenesis: kidney complications and renal failure
- PMID: 21983749
- PMCID: PMC3779650
- DOI: 10.1007/82_2011_172
Shiga toxin pathogenesis: kidney complications and renal failure
Abstract
The kidneys are the major organs affected in diarrhea-associated hemolytic uremic syndrome (D(+)HUS). The pathophysiology of renal disease in D(+)HUS is largely the result of the interaction between bacterial virulence factors such as Shiga toxin and lipopolysaccharide and host cells in the kidney and in the blood circulation. This chapter describes in detail the current knowledge of how these bacterial toxins may lead to kidney disease and renal failure. The toxin receptors expressed by specific blood and resident renal cell types are also discussed as are the actions of the toxins on these cells.
Similar articles
-
Pathogenesis of Shiga toxin-associated hemolytic uremic syndrome.Pediatr Res. 2001 Aug;50(2):163-71. doi: 10.1203/00006450-200108000-00002. Pediatr Res. 2001. PMID: 11477199 Review.
-
The role of coagulation and fibrinolysis in the pathogenesis of diarrhea-associated hemolytic uremic syndrome.Semin Thromb Hemost. 2001 Jun;27(3):201-5. doi: 10.1055/s-2001-15249. Semin Thromb Hemost. 2001. PMID: 11446653 Review.
-
Human renal microvascular endothelial cells as a potential target in the development of the hemolytic uremic syndrome as related to fibrinolysis factor expression, in vitro.Microvasc Res. 1994 May;47(3):377-87. doi: 10.1006/mvre.1994.1030. Microvasc Res. 1994. PMID: 8084301
-
Microvesicle Involvement in Shiga Toxin-Associated Infection.Toxins (Basel). 2017 Nov 19;9(11):376. doi: 10.3390/toxins9110376. Toxins (Basel). 2017. PMID: 29156596 Free PMC article. Review.
-
The role of the endothelium in hemolytic uremic syndrome.J Nephrol. 2001 Nov-Dec;14 Suppl 4:S58-62. J Nephrol. 2001. PMID: 11798147 Review.
Cited by
-
Action of shiga toxin type-2 and subtilase cytotoxin on human microvascular endothelial cells.PLoS One. 2013 Jul 30;8(7):e70431. doi: 10.1371/journal.pone.0070431. Print 2013. PLoS One. 2013. PMID: 23936204 Free PMC article.
-
Shiga Toxins: An Update on Host Factors and Biomedical Applications.Toxins (Basel). 2021 Mar 18;13(3):222. doi: 10.3390/toxins13030222. Toxins (Basel). 2021. PMID: 33803852 Free PMC article. Review.
-
Effects of Shiga toxin type 2 on a bioengineered three-dimensional model of human renal tissue.Infect Immun. 2015 Jan;83(1):28-38. doi: 10.1128/IAI.02143-14. Epub 2014 Oct 13. Infect Immun. 2015. PMID: 25312954 Free PMC article.
-
Shiga toxin remodels the intestinal epithelial transcriptional response to Enterohemorrhagic Escherichia coli.PLoS Pathog. 2021 Feb 2;17(2):e1009290. doi: 10.1371/journal.ppat.1009290. eCollection 2021 Feb. PLoS Pathog. 2021. PMID: 33529199 Free PMC article.
-
Flagellin Induces β-Defensin 2 in Human Colonic Ex vivo Infection with Enterohemorrhagic Escherichia coli.Front Cell Infect Microbiol. 2016 Jun 21;6:68. doi: 10.3389/fcimb.2016.00068. eCollection 2016. Front Cell Infect Microbiol. 2016. PMID: 27446815 Free PMC article.
References
-
- Aderem A, Ulevitch RJ. Toll-like receptors in the induction of the innate immune response. Nature. 2000;406:782–787. - PubMed
-
- Ahn CK, Holt NJ, Tarr PI. Shiga-toxin producing Escherichia coli and the hemolytic uremic syndrome: what have we learned in the past 25 years? Adv Exp Med Biol. 2009;634:1–17. - PubMed
-
- Appiani AC, Edefonti A, Bettinelli A, Cossu MM, Paracchini ML, Rossi E. The relationship between plasma levels of the factor VIII complex and platelet release products (beta-thromboglobulin and platelet factor 4) in children with the hemolytic-uremic syndrome. Clin Nephrol. 1982;17:195–199. - PubMed
-
- Arfilli V, Carnicelli D, Rocchi L, Ricci F, Pagliaro P, Tazzari PL, Brigotti M. Shiga toxin 1 and ricin A chain bind to human polymorphonuclear leucocytes through a common receptor. Biochem J. 2010;432:173–180. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources